The future of Johnson & Johnson's cancer blockbuster Zytiga is in doubt, after a US patent ruling has opened the door to generic competitors. Johnson & Johnson’s Q4 results were hit by a one-off ...
"Millions of packages moved away from SurePost and the United States Postal Service and returned to UPS package cars this month, now being sorted and delivered by hardworking UPS Teamsters." ...
There are many I’m proud of, but I’ll mention four. The first is Zytiga at Johnson & Johnson, which is the biggest selling prostate cancer drug in the world. When I identified it for Cougar ...